top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
iScreen Shoter - 20261028172009135.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
Frame 1000008569.png
Frame 1000008568.png
4acc1a9d-ced8-4f58-a79e-cd2ac6fe752e.png
Liver Attenuation.png
Frame 1000008251.jpg
Lung LAI.jpg
lung HAI.jpg
ٍEpicardial Fat .png
coronaryArteryCalcification.png
Thoracic Aorta and Pulmonary Artery Sizing .png
iScreen Shoter - 20261028184534618.jpg
Cardiac Chambers Volumetry.png
iScreen Shoter - 20261028184548151.jpg
aortic.jpg

AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI

3 hours ago
1 min read

Published research | JACC: Advances, November 2024

This study evaluates whether AI-enabled automated left atrial (LA) volumetry from routine noncontrast coronary artery calcium (CAC) CT scans can predict atrial fibrillation (AF) and stroke as effectively as expert-measured LA volume on cardiac MRI (CMRI). The work also compares these imaging measures with established risk markers.

Study design

The analysis used 15-year outcome data from 3,552 asymptomatic MESA participants who underwent both CAC CT and CMRI at baseline. CMRI LA volume had been measured by human experts. The investigators compared time-dependent discrimination for incident AF and stroke using AI-CAC LA volume, CMRI LA volume, CHARGE-AF risk score, Agatston CAC score, and NT-proBNP.

Key findings

During 15 years of follow-up, 562 AF cases and 140 strokes occurred. Discrimination was similar for AI-CAC and CMRI volumetry: AUC 0.802 versus 0.798 for AF, and 0.762 versus 0.751 for stroke; the differences were not statistically significant. Adding AI-CAC LA volume improved reclassification for 5-year AF prediction when added to CHARGE-AF (continuous NRI 0.23), NT-proBNP (0.37), or Agatston score (0.44; P<0.0001 for all).

Why it matters

The findings suggest that LA volume can be quantified from noncontrast CAC scans already obtained in clinical care, with prognostic performance comparable to expert CMRI measurements in this cohort. The authors note that further studies are needed to establish the clinical utility of AI-CAC for AF and stroke prediction.

Publication

Naghavi M, Reeves AP, Atlas KC, et al. AI-Enabled CT Cardiac Chamber Volumetry Predicts Atrial Fibrillation and Stroke Comparable to MRI. JACC: Advances. 2024;3(11):101300. doi:10.1016/j.jacadv.2024.101300. Open access under CC BY-NC-ND.

Download the full article

Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png

©2026 HeartLung Corporation. All Rights Reserved. U.S. Patent Nos. 12,620,494; 12,599,350; 11,610,686. Licensed U.S. Patent Nos. 9,119,590 and 10,695,022. U.S. Patent Applications Pending: 19/390,544; 19/403,750; 19/643,672; 19/728,738; 19/741,766; 18/652,123; 18/771,542; 19/390,629; 19/417,345; 19/467,802; 19/565,385; 19/682,416; 19/690,066. International PCT Applications: PCT/US2025/058510; PCT/US2025/061047; PCT/US2025/058505; PCT/US2026/013566; PCT/US2026/024304. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoLiver, AutoChamber, AutoLung and other product names and trademarks displayed on this website are protected by applicable intellectual property laws. All rights reserved.

bottom of page